Variation in the Humoral Immune Response Induced by the Administration of the BNT162b2 Pfizer/BioNTech Vaccine: A Systematic Review

The BNT162b2 Pfizer/BioNTech vaccine was the first emergency approved vaccine during the COVID-19 pandemic. The aim of this systematic review was to examine the variations in the humoral immune response induced by the administration of the BNT162b2 vaccine in patients with previous SARS-CoV-2 infect...

Descripción completa

Detalles Bibliográficos
Autores principales: Cortés-Sarabia, Karen, Gutiérrez-Torres, Mayralina, Mendoza-Renteria, Escarlet Maleny, Leyva-Vázquez, Marco Antonio, Vences-Velázquez, Amalia, Hernández-Sotelo, Daniel, Beltrán-Anaya, Fredy Omar, Del Moral-Hernández, Oscar, Illades-Aguiar, Berenice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229764/
https://www.ncbi.nlm.nih.gov/pubmed/35746517
http://dx.doi.org/10.3390/vaccines10060909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229764/
https://www.ncbi.nlm.nih.gov/pubmed/35746517
http://dx.doi.org/10.3390/vaccines10060909

Ejemplares similares